Clinical course and outcome of disseminated intravascular coagulation diagnosed by Japanese Association for Acute Medicine criteria

Summary

The Japanese Association for Acute Medicine (JAAM) disseminated intravascular coagulation (DIC) study group recently announced new diagnostic criteria for DIC. These criteria have been prospectively validated and demonstrated to progress to overt DIC as defined by the International Society on Thrombosis and Haemostasis (ISTH).Although an underlying condition is essential for the development of DIC, it has never been clarified if patients with different underlying disorders have a similar course. Among 329 patients with DIC diagnosed by the JAAM criteria, those with underlying sepsis (n=98) or trauma (n=95) were compared. The 28-day mortality rate was significantly higher in sepsis patients than trauma patients (34.7% vs. 10.5%, p<0.0001).Within three days of fulfilling the JAAM criteria, sepsis patients had a lower platelet count, higher prothrombin time ratio, higher systemic inflammatory response syndrome score, and higher Sequential Organ Failure Assessment score compared with trauma patients. On day 3, a significantly higher percentage of trauma patients than sepsis patients showed improvement of DIC (64.2% vs. 30.6%, p<0.001).These differences were mainly due to patients with lower JAAM DIC scores. More than 50% of the JAAM DIC patients with sepsis who died within 28 days could not be detected by ISTH DIC criteria during the initial three days. In contrast, most trauma patients who died within 28 days had DIC simultaneously diagnosed by JAAM and ISTH criteria, except for those with brain death. These findings suggest that coagulation abnormalities, organ dysfunction, and the outcome of JAAM DIC differ between patients with sepsis and trauma.

Keywords

Disseminated intravascular coagulation - diagnosis - criteria - sepsis - trauma

• References

• 1 Levi M, ten Cate H. Disseminated intravascular coagulation. N Engl J Med 1999; 341: 586-592.
• 2 Taylor Jr FB, Toh CH, Hoots WK. et al. Toward definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 2001; 86: 1327-1330.
• 3 Kobayashi N, Maekawa T, Takada M. et al. Criteria for diagnosis of DIC based on the analysis of clinical and laboratory findings in 345 DIC patients collected by the Research Committee on DIC in Japan. Bibl Haematol 1987; 49: 848-852.
• 4 Bkhtiari K, Meijers JCM, de Jonge E. et al. Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation. Crit Care Med 2004; 32: 2416-2421.
• 5 Volves C, Wuillemin WA, Zeerleder S. International Society on Thrombosis and Haemostasis score for overt disseminated intravascular coagulation predicts organ dysfunction and fatality in sepsis patients. Blood Coagul Fibrinolysis 2006; 17: 445-451.
• 6 Levi M, Joyce DE, Sundin DP. et al. Disseminated intravascular coagulation in patients with severe sepsis: Comparing current definitions. Intensive Care Med 2003; 29 (Suppl. 01) S33.
• 7 Rason D, Dwyre L, Heyland D. et al. Issues arising in application of the ISTH disseminated intravascular coagulation (DIC) scoring system: The need for modification before prospective validation. J Thromb Haemost 2003; 01 (Suppl. 01) 0583.
• 8 Gando S, Iba T, Eguchi Y. et al. A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: Comparing current criteria. Crit Care Med 2006; 34: 625-631.
• 9 Gando S, Saitoh D, Ogura H. et al. Natural history of disseminated intravascular coagulation diagnosed based on the newly established diagnostic criteria for critically ill patients: Results ofa multicenter, prospective survey. Crit Care Med 2008; 36: 145-150.
• 10 Ito K, Wada H, Abe Y. et al. Clinical evaluation of a test for plasma fibrin/fibrinogen degradation products (FDP) based on monoclonal anti-FDP antibody technology: application for the disseminated intravascular coagulation (DIC) diagnostic scoring system. Rinsho Byori 2003; 51: 295-299.
• 11 Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference committee. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definition of sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20: 864-874.
• 12 Vincent JL, de Mendonça A, Cantraine F. et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Crit Care Med 1998; 26: 1793-1800.
• 13 Gando S. Disseminated intravascular coagulation in trauma patients. Semin Thromb Hemost 2001; 27: 585-592.
• 14 Hess JR, Lawson JH. The coalulopathy of trauma versus disseminated intravascular coagulation. J Trauma 2006; 60: S12-S19.
• 15 Gando S, Nakanishi Y, Tedo I. Cytokines and plasminogen activator-1 in posttrauma disseminated intravascular coagulation: Relationship to multiple organ dysfunction syndrome. Crit Care Med 1995; 23: 1835-1842.
• 16 Brohi K, Cohen MJ, Davenport RA. Acute coagulopathy of trauma: mechanism, identification and effect. Curr Opin Crit Care 2007; 13: 680-685.
• 17 Levi M, de Jonge E, van der Poll T. Sepsis and disseminated intravascular coagulation. J Thromb Thrombolysis 2003; 16: 43-47.
• 18 Dempfle CE. Coagulopathy of sepsis. Thromb Haemost 2004; 91: 213-224.